Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies.

Orbus is committed to bringing innovative products to the extremely under served patients affected by rare diseases. They are focused and passionate about bringing a more positive outcome to patients facing life threatening or significantly life altering diseases.

Currently Orbus Therapeutics is working to develop and commercialize eflornithine in North America.